Assignee
SHANGHAI BIOMABS PHARMACEUTICALS CO LTD
CN·2 granted patents·3 citations·filing 2016–2016
Top patents by PatentIndex Score
2 records- 0164US10118966B2Anti-EGFR monoclonal antibody, methods of making, and uses thereof in the treatment of cancerSHANGHAI BIOMABS PHARMACEUTICALS CO LTD·Filed 2016·Granted Nov 6, 2018·3 cites·42 claims
- 0226US11014981B2Method for preparing new type of recombinant anti-TNF-α chimeric monoclonal antibody and useSHANGHAI BIOMABS PHARMACEUTICALS CO LTD·Filed 2016·Granted May 25, 2021·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI BIOMABS PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →